Médica Sur, S.A.B. de C.V.

BMV:MEDICA B Stock Report

Market Cap: Mex$3.7b

Médica Sur. de Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Carlos Quintana

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureno data

Recent management updates

No updates

Recent updates

Médica Sur. de (BMV:MEDICAB) Is Doing The Right Things To Multiply Its Share Price

Sep 24
Médica Sur. de (BMV:MEDICAB) Is Doing The Right Things To Multiply Its Share Price

Does Médica Sur. de (BMV:MEDICAB) Have A Healthy Balance Sheet?

Dec 19
Does Médica Sur. de (BMV:MEDICAB) Have A Healthy Balance Sheet?

Is Médica Sur. de (BMV:MEDICAB) A Risky Investment?

Aug 30
Is Médica Sur. de (BMV:MEDICAB) A Risky Investment?

A Look At The Fair Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)

Jun 02
A Look At The Fair Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)

Why We Like The Returns At Médica Sur. de (BMV:MEDICAB)

Dec 03
Why We Like The Returns At Médica Sur. de (BMV:MEDICAB)

Investors Shouldn't Overlook Médica Sur. de's (BMV:MEDICAB) Impressive Returns On Capital

Jun 07
Investors Shouldn't Overlook Médica Sur. de's (BMV:MEDICAB) Impressive Returns On Capital

These 4 Measures Indicate That Médica Sur. de (BMV:MEDICAB) Is Using Debt Safely

May 09
These 4 Measures Indicate That Médica Sur. de (BMV:MEDICAB) Is Using Debt Safely

A Look At The Intrinsic Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)

Apr 18
A Look At The Intrinsic Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)

Médica Sur, S.A.B. de C.V.'s (BMV:MEDICAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Mar 07
Médica Sur, S.A.B. de C.V.'s (BMV:MEDICAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Can You Imagine How Médica Sur. de's (BMV:MEDICAB) Shareholders Feel About The 74% Share Price Increase?

Feb 07
Can You Imagine How Médica Sur. de's (BMV:MEDICAB) Shareholders Feel About The 74% Share Price Increase?

Médica Sur. de (BMV:MEDICAB) Has A Pretty Healthy Balance Sheet

Jan 17
Médica Sur. de (BMV:MEDICAB) Has A Pretty Healthy Balance Sheet

Could The Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Ownership Structure Tell Us Something Useful?

Dec 26
Could The Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Ownership Structure Tell Us Something Useful?

Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Nov 29
Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

CEO

Carlos Quintana

less than a year

Tenure

Dr. Carlos Arellano Quintana is Chief Executive Officer of Médica Sur, S.A.B. de C.V. from March 21, 2024. Dr. Quintana attended Boston University Questrom School Of Business.

Leadership Team

NamePositionTenureCompensationOwnership
Carlos Quintana
Chief Executive Officerless than a yearno datano data
Aurora Zarate
Head of Finance & Administrationno datano datano data
Jose Correa Rovelo
Director of Operations & Directorless than a yearno datano data
Arely Gutierrez
Deputy Director of Financing & Investor Relationsno datano datano data
Juan Antonio Nieves
Director of Human Resourcesno datano datano data
Octavio Chon
Chief Medical Officer & Directorno datano datano data
Jaime Arriaga Gracia
Chief Strategyno datano datano data
Martha Helena Ostos
Director of the Center for Clinical Diagnosis & Imaging and Executive Directorno datano datano data
Salvador Rivero Boschert
Executive Director1.8yrsno datano data
José Pérez Jáuregui
Chief Corporate Laboratory Officerno datano datano data
Cuauhtémoc Santa-Ana Otero
Secretaryno datano datano data
Sandra Del Carmen Garcia Lopez
Director of Medicine & Hospitalizationno datano datano data

0.8yrs

Average Tenure

Experienced Management: MEDICA B's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 01:00
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Médica Sur, S.A.B. de C.V. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martín LaraMiranda Global Research